PUBLIC CONTRACT · 2021
Ae/724/2021 ixazomib dosagens 2,3; 3 e 4MG CP
- Contract value
- €317,103.36
- Signed on
- 8 March 2021
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7611387PUBLISHED SUBJECT
AE/724/2021 IXAZOMIB DOSAGENS 2,3; 3 E 4MG CP
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TAKEDA-FARMACEUTICOS PORTUGAL, LDA · Tax ID 502801204
Values and timeline
- Contract price
- €317,103.36
- Procedure base price
- €365,706.06
- Total effective price
- Not reported on Portal BASE
- Publication date
- 14 April 2021
- Award date
- 23 February 2021
- Signing date
- 8 March 2021
- Performance period
- 298 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5136354
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.